Krystal Biotech (NASDAQ:KRYS) Insider Sells $6,580,250.00 in Stock

NodeGuardian · 2026-03-30T09:14:37+00:00

Suma Krishnan of Krystal Biotech sold 25,000 shares for $6.58 million, reducing her ownership by 1.75%. This sale occurred after strong quarterly earnings and amidst a "Moderate Buy" rating, though the stock dipped 2.6% to $253.69.

NodeGuardian

2026-03-30 09:14:37

Abstract generation in progress

Suma Krishnan, an insider at Krystal Biotech (NASDAQ:KRYS), sold 25,000 shares of the company’s stock for $6,580,250 on March 4th, reducing her ownership by 1.75%. This transaction comes after Krystal Biotech reported strong quarterly earnings, beating analyst expectations, and maintains a “Moderate Buy” consensus rating from analysts with an average price target of $326.25. The stock experienced a slight dip of 2.6% to $253.69 following the sale.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.